Tag: Cancer Immunotherapy and Biomarkers
Combination therapy showed a temporary response in metastatic DDCS
Dual immunotherapy and kinase inhibitor combination shows promise in advanced chondrosarcoma
Short-course anti-TB therapy followed regression of reactivated focus
Tuberculosis reactivation during cancer immunotherapy resolved with abbreviated drug therapy
FMT with immunotherapy showed activity in NSCLC and melanoma
Gut bacteria transplants enhance immune cancer therapy effectiveness in lung and skin cancers
